Join our webinar to discuss IsoPlexis’ product suite capabilities and how functional phenotyping is addressing urgent challenges central to unlocking the next stage of personalized cancer immunotherapies and vaccines related to immunological mechanisms in infectious disease. With single cell proteomics barcoding and detection of a full range of cytokines (30+) per single cell across thousands of single cells, the IsoLight platform is showing the unique value of resolving the heterogeneity of a variety of immune cell types, lucidating key pre clinical translational biomarkers to accelerate research and discovery.